The type I transmembrane collagen receptor Endo180 (CD280, CLEC13E, KIAA0709, MRC2, TEM9, uPARAP) is as a strong prognostic indicator for prostate cancer survival [17, 18]. Here, MRC2 is linked to prostate cancer.